428 related articles for article (PubMed ID: 37964279)
1. Insights into the regulatory role of RNA methylation modifications in glioma.
Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
[TBL] [Abstract][Full Text] [Related]
2. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
3. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
Liu Y; Zhu J; Ding L
Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
Cusenza VY; Tameni A; Neri A; Frazzi R
Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
[TBL] [Abstract][Full Text] [Related]
6. The potential regulatory role of RNA methylation in ovarian cancer.
Zhao S; Zhang M; Zhu X; Xing J; Zhou J; Yin X
RNA Biol; 2023 Jan; 20(1):207-218. PubMed ID: 37194218
[TBL] [Abstract][Full Text] [Related]
7. The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives.
Chen Y; Jiang Z; Yang Y; Zhang C; Liu H; Wan J
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126773. PubMed ID: 37690652
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of RNA methylation in gastrointestinal cancers.
Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
[TBL] [Abstract][Full Text] [Related]
9. The role of RNA modification in hepatocellular carcinoma.
Feng Q; Wang D; Xue T; Lin C; Gao Y; Sun L; Jin Y; Liu D
Front Pharmacol; 2022; 13():984453. PubMed ID: 36120301
[TBL] [Abstract][Full Text] [Related]
10. The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs.
Jacob R; Zander S; Gutschner T
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125541
[TBL] [Abstract][Full Text] [Related]
11. The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark.
Trixl L; Lusser A
Wiley Interdiscip Rev RNA; 2019 Jan; 10(1):e1510. PubMed ID: 30311405
[TBL] [Abstract][Full Text] [Related]
12. New insights into the plant epitranscriptome.
Vandivier LE; Gregory BD
J Exp Bot; 2018 Sep; 69(20):4659-4665. PubMed ID: 30020491
[TBL] [Abstract][Full Text] [Related]
13. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.
Zhou W; Wang X; Chang J; Cheng C; Miao C
Crit Rev Clin Lab Sci; 2022 May; 59(3):203-218. PubMed ID: 34775884
[TBL] [Abstract][Full Text] [Related]
14. The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses.
Adamopoulos PG; Athanasopoulou K; Daneva GN; Scorilas A
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768716
[TBL] [Abstract][Full Text] [Related]
15. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
[TBL] [Abstract][Full Text] [Related]
16. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
Petri BJ; Klinge CM
J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
[TBL] [Abstract][Full Text] [Related]
17. Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine.
Xu Y; Zhang M; Zhang Q; Yu X; Sun Z; He Y; Guo W
Front Cell Dev Biol; 2021; 9():767668. PubMed ID: 34917614
[TBL] [Abstract][Full Text] [Related]
18. Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS.
Chokkalla AK; Mehta SL; Vemuganti R
Transl Stroke Res; 2022 Feb; 13(1):1-11. PubMed ID: 34224107
[TBL] [Abstract][Full Text] [Related]
19. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq.
Li W; Li X; Ma X; Xiao W; Zhang J
BMC Genomics; 2022 Feb; 23(1):105. PubMed ID: 35135476
[TBL] [Abstract][Full Text] [Related]
20. RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer.
Wang Y; Mao Y; Wang C; Jiang X; Tang Q; Wang L; Zhu J; Zhao M
Ann Med; 2023 Dec; 55(1):2190618. PubMed ID: 37042849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
